Coherus Oncology, Inc. - Common Stock (CHRS)

CUSIP: 19249H103

Q2 2018 13F Holders as of 30 Jun 2018

Holder snapshot 7 signals
Share change
+6,677,228
Put/Call ratio
68%
SEC-reported price per share
$14.00
Indexed holders
112
Value change
+$96,221,276
Number of buys
74
Open additional details 1 more signal available
Number of sells
38
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
154,050,897

Security key

19249H103

Report period

Q2 2018

Indexed institutions

112

Top holders

10

Ownership snapshot

Top reported holders of CHRS - Coherus Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
0/15
Latest evidence
31 Mar 2018
13F Highest disclosed value: $86,038,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP has the largest disclosed position value at $86.04M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Disclosed position value Top 5
WELLINGTON MANAGEMENT GROUP LLP $86.04M
FMR LLC $82.73M
Temasek Holdings (Private) Ltd $72.44M
BlackRock Finance, Inc. $36.84M
Kohlberg Kravis Roberts & Co. L.P. $33.76M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$86,038,000
7,786,287 shares
— 31 Mar 2018
FMR LLC
13F
Company
13F
—
denominator unverified
$82,733,000
7,487,137 shares
— 31 Mar 2018
Temasek Holdings (Private) Ltd
13F
Company
13F
—
denominator unverified
$72,445,000
6,556,116 shares
— 31 Mar 2018
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$36,837,000
3,333,724 shares
— 31 Mar 2018
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
13F
—
denominator unverified
$33,758,000
3,055,055 shares
— 31 Mar 2018
Sofinnova Investments, Inc.
13F
Company
13F
—
denominator unverified
$31,970,000
2,893,221 shares
— 31 Mar 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
112
Shares
61,953,349
Indexed holders
112
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 indexed holders
102
Q2 2018 indexed holders
112
Indexed holder difference
10
Investor Q1 2018 Shares Q2 2018 Shares Share Diff Share Chg % Q1 2018 value Q2 2018 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .